Mindray Announces Option Exchange Offer
11 Marzo 2009 - 12:00PM
PR Newswire (US)
SHENZHEN, China, March 11 /PRNewswire-Asia-FirstCall/ -- Mindray
Medical International Limited (NYSE:MR), a leading developer,
manufacturer and marketer of medical devices worldwide, today
announced that its Board of Directors has authorized an option
exchange program for certain options granted under the Mindray
Medical International Limited Share Incentive Plan (the "Share
Incentive Plan"). This exchange program, which is only available to
eligible employees, is expected to provide additional incentive and
retention value. Under the terms of the exchange, participants will
be able to tender vested and unvested outstanding options to
purchase Class A ordinary shares of Mindray which have an exercise
price greater than $24.00 per share in exchange for a lower number
of newly granted options. The exercise price of the new options
will be the closing price of Mindray common stock on the New York
Stock Exchange on the exchange date. Mindray expects the offer to
expire on March 15, 2009 and expects to grant the replacement
options on March 16, 2009. The option exchange program is designed
so that the current fair value of the options surrendered is
similar to the fair value of the replacement options, and any
additional expenses due to the exchange offer should be minimal.
Cautionary Note Regarding Forward-Looking Statements This press
release contains "forward-looking statements" related to our offer
to exchange certain stock options for replacement options. These
statements are not historical facts but instead represent only our
belief regarding future events, many of which, by their nature, are
inherently uncertain and outside of our control. Such information
speaks only as of the date of this announcement, and we undertake
no obligation to update or revise these forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by law. About Mindray Mindray is a leading
developer, manufacturer and marketer of medical devices worldwide.
Established in 1991, Mindray offers a broad range of products
across three primary business segments: patient monitoring &
life support products, in-vitro diagnostic products and medical
imaging systems. Mindray is globally headquartered in Shenzhen,
China, with U.S. headquarters in Mahwah, New Jersey. Mindray also
has another 12 international sales and service offices in
Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow,
Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver. For more
information, please visit http://www.mindray.com/ . For investor
and media inquiries please contact: In the U.S: Evan Smith, CFA FD
Tel: +1-212-850-5606 Email: John Capodanno FD Tel: +1-212-850-5705
Email: In China: May Li Mindray Investor Relations Tel:
+86-755-2658-2518 Email: DATASOURCE: Mindray Medical International
Limited CONTACT: Evan Smith, CFA, +1-212-850-5606, or , or John
Capodanno, +1-212-850-5705, or , of FD for Mindray Medical
International Limited, or in China, May Li, of Mindray Investor
Relations, +86-755-2658-2518, or Web site: http://www.mindray.com/
Copyright
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Lug 2023 a Lug 2024